Breakthrough Microvascular Imaging Technology Demonstrated at French Radiology Congress

The technology also provides real time, detailed information to physicians, for the diagnosis of cancerous lesions.

The technology, called AngioPLUS – PLanewave UltraSensitive imaging, was developed by SuperSonic Imagine (Aix-en-Provence, France), pioneers of ShearWave Elastography. SuperSonic Imagine plans to implement AngioPLUS on its Aixplorer ultrasound system, to help clinicians diagnose cancerous lesions in lymph nodes, thyroid, liver, and breast, by enabling visualization of microvascularization and vessel flow of the lesions. AngioPLUS is an important addition to existing noninvasive tools for diagnosing cancer.

Another application of AngioPLUS is for the identification of low-grade tendon inflammation in musculoskeletal assessments.

The SuperSonic Imagine Aixplorer ultrasound system, together with the UltraFast platform can acquire images 200 times faster than conventional ultrasound systems, and is the only system that can image two types of ultrasound waves. The system can help clinicians visualize, and analyze tissue stiffness reliably, in real-time, to ensure high image quality and shear waves.

Prof. Jean-Michel Correas, vice chairman, Adult Radiology Department, Necker University Hospital (Paris, France), said, “The AngioPLUS technology significantly improves flow sensitivity in color imaging. This innovation allows physicians to quickly and accurately address challenging clinical situations such as characterizing fortuitously discovered focal liver lesions and renal blood flow disturbance. We believe AngioPLUS can help avoid additional imaging or biopsy procedures”.

Related Links:
SuperSonic Imagine